Kynam Capital Management, LP Cabaletta Bio, Inc. Transaction History

Kynam Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.64 - $9.3 $231,884 - $3.37 Million	-362,319 Reduced 68.65%	165,486 $1.53 Million
Q3 2022 Nov 14, 2022	SELL	$0.63 - $2.05 $11,966 - $38,939	-18,995 Reduced 3.47%	527,805 $343,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $2.11 $68,631 - $146,275	-69,325 Reduced 11.25%	546,800 $580,000
Q1 2022 May 13, 2022	SELL	$1.68 - $3.92 $47,809 - $111,555	-28,458 Reduced 4.41%	616,125 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $2.17 Million - $9.44 Million	644,583 New	644,583 $2.44 Million

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Kynam Capital Management, LP with notifications on news.